GLUCOSE SENSOR MARKET ANALYSIS

Glucose Sensor Market, by Product Type (Non-invasive (Optical Sensors and Transdermal Sensors), Invasive (Intravenous Implantable, Micro Dialysis, and Subcutaneous Sensor), and Minimally Invasive (Micro Pore/ Micro Needles)), by Technology (Polarimetry, Raman Spectroscopy, (Near) Infrared Spectroscopy, MIR Spectroscopy, Impedance Spectroscopy, Fluorescence, Photo-Acoustic Spectroscopy, Optical Coherence Tomography, Skin Suction Blister Technique, Sonophoresis, and Reverse Iontophoresis), by Distribution Channel (Hospitals, Clinics, Home Care Settings, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2490
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key players operating in the global glucose sensor market include, Abbott Diagnostics, Pinnacle Technologies, Inc., 77 Elektronika KFT, Sanofi-Deutschland GmbH, Life Scan (Johnson and Johnson Company), Universal Biosensors, Diamontech GmbH, Medical Wireless Sensing Ltd, Medtronic MiniMed, Inc. Bayer Healthcare, DexCom Inc., Nova Biomedical Corporation, Terumo Europe NV, Arkay, Inc., and Roche Diagnostics.